NCT02045693View on ClinicalTrials.gov

Drug Interaction & Methadone & Buprenorphine

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Hepatitis C
Interventions
DRUG

Methadone

DRUG

DCV 3DAA FDC

DRUG

BMS-791325

DRUG

Buprenorphine

DRUG

Naloxone

Trial Locations (3)

19139

Cri Lifetree, Philadelphia

84106

Lifetree Clinical Research, Salt Lake City

92801

Anaheim Clinical Trials Llc, Anaheim

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY